img

Global Nerve Block Injection Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nerve Block Injection Market Research Report 2024

Nerve block injection is a local anesthetic used during surgery to control pain and reduce or eliminate the use of opioids for acute postoperative pain.
According to QYResearch’s new survey, global Nerve Block Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nerve Block Injection market research.
Key manufacturers engaged in the Nerve Block Injection industry include Pfizer, Pacira, Fresenius Kabi, Aspen Pharmacare, AstraZeneca, Eugia US, Aurobindo, Akorn and Somerset Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Nerve Block Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nerve Block Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nerve Block Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Pacira
Fresenius Kabi
Aspen Pharmacare
AstraZeneca
Eugia US
Aurobindo
Akorn
Somerset Pharma
Amphastar Pharmaceuticals
Hikma
Segment by Type
Esters Local Anesthetics
Amide Local Anesthetics

Segment by Application


Hospital
Clinic
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nerve Block Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Nerve Block Injection Market Overview
1.1 Product Overview and Scope of Nerve Block Injection
1.2 Nerve Block Injection Segment by Type
1.2.1 Global Nerve Block Injection Market Value Comparison by Type (2024-2034)
1.2.2 Esters Local Anesthetics
1.2.3 Amide Local Anesthetics
1.3 Nerve Block Injection Segment by Application
1.3.1 Global Nerve Block Injection Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Nerve Block Injection Market Size Estimates and Forecasts
1.4.1 Global Nerve Block Injection Revenue 2018-2034
1.4.2 Global Nerve Block Injection Sales 2018-2034
1.4.3 Global Nerve Block Injection Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Nerve Block Injection Market Competition by Manufacturers
2.1 Global Nerve Block Injection Sales Market Share by Manufacturers (2018-2024)
2.2 Global Nerve Block Injection Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Nerve Block Injection Average Price by Manufacturers (2018-2024)
2.4 Global Nerve Block Injection Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Nerve Block Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nerve Block Injection, Product Type & Application
2.7 Nerve Block Injection Market Competitive Situation and Trends
2.7.1 Nerve Block Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nerve Block Injection Players Market Share by Revenue
2.7.3 Global Nerve Block Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nerve Block Injection Retrospective Market Scenario by Region
3.1 Global Nerve Block Injection Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Nerve Block Injection Global Nerve Block Injection Sales by Region: 2018-2034
3.2.1 Global Nerve Block Injection Sales by Region: 2018-2024
3.2.2 Global Nerve Block Injection Sales by Region: 2024-2034
3.3 Global Nerve Block Injection Global Nerve Block Injection Revenue by Region: 2018-2034
3.3.1 Global Nerve Block Injection Revenue by Region: 2018-2024
3.3.2 Global Nerve Block Injection Revenue by Region: 2024-2034
3.4 North America Nerve Block Injection Market Facts & Figures by Country
3.4.1 North America Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Nerve Block Injection Sales by Country (2018-2034)
3.4.3 North America Nerve Block Injection Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nerve Block Injection Market Facts & Figures by Country
3.5.1 Europe Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Nerve Block Injection Sales by Country (2018-2034)
3.5.3 Europe Nerve Block Injection Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nerve Block Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Nerve Block Injection Sales by Country (2018-2034)
3.6.3 Asia Pacific Nerve Block Injection Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nerve Block Injection Market Facts & Figures by Country
3.7.1 Latin America Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Nerve Block Injection Sales by Country (2018-2034)
3.7.3 Latin America Nerve Block Injection Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nerve Block Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Nerve Block Injection Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Nerve Block Injection Sales by Country (2018-2034)
3.8.3 Middle East and Africa Nerve Block Injection Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nerve Block Injection Sales by Type (2018-2034)
4.1.1 Global Nerve Block Injection Sales by Type (2018-2024)
4.1.2 Global Nerve Block Injection Sales by Type (2024-2034)
4.1.3 Global Nerve Block Injection Sales Market Share by Type (2018-2034)
4.2 Global Nerve Block Injection Revenue by Type (2018-2034)
4.2.1 Global Nerve Block Injection Revenue by Type (2018-2024)
4.2.2 Global Nerve Block Injection Revenue by Type (2024-2034)
4.2.3 Global Nerve Block Injection Revenue Market Share by Type (2018-2034)
4.3 Global Nerve Block Injection Price by Type (2018-2034)
5 Segment by Application
5.1 Global Nerve Block Injection Sales by Application (2018-2034)
5.1.1 Global Nerve Block Injection Sales by Application (2018-2024)
5.1.2 Global Nerve Block Injection Sales by Application (2024-2034)
5.1.3 Global Nerve Block Injection Sales Market Share by Application (2018-2034)
5.2 Global Nerve Block Injection Revenue by Application (2018-2034)
5.2.1 Global Nerve Block Injection Revenue by Application (2018-2024)
5.2.2 Global Nerve Block Injection Revenue by Application (2024-2034)
5.2.3 Global Nerve Block Injection Revenue Market Share by Application (2018-2034)
5.3 Global Nerve Block Injection Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Nerve Block Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Pacira
6.2.1 Pacira Corporation Information
6.2.2 Pacira Description and Business Overview
6.2.3 Pacira Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Pacira Nerve Block Injection Product Portfolio
6.2.5 Pacira Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Fresenius Kabi Nerve Block Injection Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Aspen Pharmacare
6.4.1 Aspen Pharmacare Corporation Information
6.4.2 Aspen Pharmacare Description and Business Overview
6.4.3 Aspen Pharmacare Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Aspen Pharmacare Nerve Block Injection Product Portfolio
6.4.5 Aspen Pharmacare Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.5.4 AstraZeneca Nerve Block Injection Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Eugia US
6.6.1 Eugia US Corporation Information
6.6.2 Eugia US Description and Business Overview
6.6.3 Eugia US Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Eugia US Nerve Block Injection Product Portfolio
6.6.5 Eugia US Recent Developments/Updates
6.7 Aurobindo
6.6.1 Aurobindo Corporation Information
6.6.2 Aurobindo Description and Business Overview
6.6.3 Aurobindo Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Aurobindo Nerve Block Injection Product Portfolio
6.7.5 Aurobindo Recent Developments/Updates
6.8 Akorn
6.8.1 Akorn Corporation Information
6.8.2 Akorn Description and Business Overview
6.8.3 Akorn Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Akorn Nerve Block Injection Product Portfolio
6.8.5 Akorn Recent Developments/Updates
6.9 Somerset Pharma
6.9.1 Somerset Pharma Corporation Information
6.9.2 Somerset Pharma Description and Business Overview
6.9.3 Somerset Pharma Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Somerset Pharma Nerve Block Injection Product Portfolio
6.9.5 Somerset Pharma Recent Developments/Updates
6.10 Amphastar Pharmaceuticals
6.10.1 Amphastar Pharmaceuticals Corporation Information
6.10.2 Amphastar Pharmaceuticals Description and Business Overview
6.10.3 Amphastar Pharmaceuticals Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Amphastar Pharmaceuticals Nerve Block Injection Product Portfolio
6.10.5 Amphastar Pharmaceuticals Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Nerve Block Injection Description and Business Overview
6.11.3 Hikma Nerve Block Injection Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Hikma Nerve Block Injection Product Portfolio
6.11.5 Hikma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nerve Block Injection Industry Chain Analysis
7.2 Nerve Block Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nerve Block Injection Production Mode & Process
7.4 Nerve Block Injection Sales and Marketing
7.4.1 Nerve Block Injection Sales Channels
7.4.2 Nerve Block Injection Distributors
7.5 Nerve Block Injection Customers
8 Nerve Block Injection Market Dynamics
8.1 Nerve Block Injection Industry Trends
8.2 Nerve Block Injection Market Drivers
8.3 Nerve Block Injection Market Challenges
8.4 Nerve Block Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nerve Block Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Nerve Block Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Nerve Block Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nerve Block Injection Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Nerve Block Injection Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Nerve Block Injection Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Nerve Block Injection Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Nerve Block Injection Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Nerve Block Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Nerve Block Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nerve Block Injection, Product Type & Application
Table 12. Global Key Manufacturers of Nerve Block Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nerve Block Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nerve Block Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nerve Block Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Nerve Block Injection Sales by Region (2018-2024) & (K Units)
Table 18. Global Nerve Block Injection Sales Market Share by Region (2018-2024)
Table 19. Global Nerve Block Injection Sales by Region (2024-2034) & (K Units)
Table 20. Global Nerve Block Injection Sales Market Share by Region (2024-2034)
Table 21. Global Nerve Block Injection Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Nerve Block Injection Revenue Market Share by Region (2018-2024)
Table 23. Global Nerve Block Injection Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Nerve Block Injection Revenue Market Share by Region (2024-2034)
Table 25. North America Nerve Block Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 27. North America Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 28. North America Nerve Block Injection Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Nerve Block Injection Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Nerve Block Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 32. Europe Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 33. Europe Nerve Block Injection Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Nerve Block Injection Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Nerve Block Injection Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Nerve Block Injection Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Nerve Block Injection Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Nerve Block Injection Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Nerve Block Injection Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Nerve Block Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Nerve Block Injection Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Nerve Block Injection Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Nerve Block Injection Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Nerve Block Injection Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Nerve Block Injection Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Nerve Block Injection Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Nerve Block Injection Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Nerve Block Injection Sales (K Units) by Type (2018-2024)
Table 51. Global Nerve Block Injection Sales (K Units) by Type (2024-2034)
Table 52. Global Nerve Block Injection Sales Market Share by Type (2018-2024)
Table 53. Global Nerve Block Injection Sales Market Share by Type (2024-2034)
Table 54. Global Nerve Block Injection Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Nerve Block Injection Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Nerve Block Injection Revenue Market Share by Type (2018-2024)
Table 57. Global Nerve Block Injection Revenue Market Share by Type (2024-2034)
Table 58. Global Nerve Block Injection Price (US$/Unit) by Type (2018-2024)
Table 59. Global Nerve Block Injection Price (US$/Unit) by Type (2024-2034)
Table 60. Global Nerve Block Injection Sales (K Units) by Application (2018-2024)
Table 61. Global Nerve Block Injection Sales (K Units) by Application (2024-2034)
Table 62. Global Nerve Block Injection Sales Market Share by Application (2018-2024)
Table 63. Global Nerve Block Injection Sales Market Share by Application (2024-2034)
Table 64. Global Nerve Block Injection Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Nerve Block Injection Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Nerve Block Injection Revenue Market Share by Application (2018-2024)
Table 67. Global Nerve Block Injection Revenue Market Share by Application (2024-2034)
Table 68. Global Nerve Block Injection Price (US$/Unit) by Application (2018-2024)
Table 69. Global Nerve Block Injection Price (US$/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Nerve Block Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Pacira Corporation Information
Table 76. Pacira Description and Business Overview
Table 77. Pacira Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Pacira Nerve Block Injection Product
Table 79. Pacira Recent Developments/Updates
Table 80. Fresenius Kabi Corporation Information
Table 81. Fresenius Kabi Description and Business Overview
Table 82. Fresenius Kabi Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Fresenius Kabi Nerve Block Injection Product
Table 84. Fresenius Kabi Recent Developments/Updates
Table 85. Aspen Pharmacare Corporation Information
Table 86. Aspen Pharmacare Description and Business Overview
Table 87. Aspen Pharmacare Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Aspen Pharmacare Nerve Block Injection Product
Table 89. Aspen Pharmacare Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. AstraZeneca Nerve Block Injection Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Eugia US Corporation Information
Table 96. Eugia US Description and Business Overview
Table 97. Eugia US Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Eugia US Nerve Block Injection Product
Table 99. Eugia US Recent Developments/Updates
Table 100. Aurobindo Corporation Information
Table 101. Aurobindo Description and Business Overview
Table 102. Aurobindo Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Aurobindo Nerve Block Injection Product
Table 104. Aurobindo Recent Developments/Updates
Table 105. Akorn Corporation Information
Table 106. Akorn Description and Business Overview
Table 107. Akorn Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Akorn Nerve Block Injection Product
Table 109. Akorn Recent Developments/Updates
Table 110. Somerset Pharma Corporation Information
Table 111. Somerset Pharma Description and Business Overview
Table 112. Somerset Pharma Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Somerset Pharma Nerve Block Injection Product
Table 114. Somerset Pharma Recent Developments/Updates
Table 115. Amphastar Pharmaceuticals Corporation Information
Table 116. Amphastar Pharmaceuticals Description and Business Overview
Table 117. Amphastar Pharmaceuticals Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Amphastar Pharmaceuticals Nerve Block Injection Product
Table 119. Amphastar Pharmaceuticals Recent Developments/Updates
Table 120. Hikma Corporation Information
Table 121. Hikma Description and Business Overview
Table 122. Hikma Nerve Block Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Hikma Nerve Block Injection Product
Table 124. Hikma Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Nerve Block Injection Distributors List
Table 128. Nerve Block Injection Customers List
Table 129. Nerve Block Injection Market Trends
Table 130. Nerve Block Injection Market Drivers
Table 131. Nerve Block Injection Market Challenges
Table 132. Nerve Block Injection Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nerve Block Injection
Figure 2. Global Nerve Block Injection Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Nerve Block Injection Market Share by Type in 2022 & 2034
Figure 4. Esters Local Anesthetics Product Picture
Figure 5. Amide Local Anesthetics Product Picture
Figure 6. Global Nerve Block Injection Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Nerve Block Injection Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Nerve Block Injection Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Nerve Block Injection Market Size (2018-2034) & (US$ Million)
Figure 13. Global Nerve Block Injection Sales (2018-2034) & (K Units)
Figure 14. Global Nerve Block Injection Average Price (US$/Unit) & (2018-2034)
Figure 15. Nerve Block Injection Report Years Considered
Figure 16. Nerve Block Injection Sales Share by Manufacturers in 2022
Figure 17. Global Nerve Block Injection Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Nerve Block Injection Players: Market Share by Revenue in 2022
Figure 19. Nerve Block Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Nerve Block Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Nerve Block Injection Sales Market Share by Country (2018-2034)
Figure 22. North America Nerve Block Injection Revenue Market Share by Country (2018-2034)
Figure 23. United States Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Nerve Block Injection Sales Market Share by Country (2018-2034)
Figure 26. Europe Nerve Block Injection Revenue Market Share by Country (2018-2034)
Figure 27. Germany Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Nerve Block Injection Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Nerve Block Injection Revenue Market Share by Region (2018-2034)
Figure 34. China Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Southeast Asia Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Latin America Nerve Block Injection Sales Market Share by Country (2018-2034)
Figure 42. Latin America Nerve Block Injection Revenue Market Share by Country (2018-2034)
Figure 43. Mexico Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Brazil Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Argentina Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Colombia Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Nerve Block Injection Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Nerve Block Injection Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Nerve Block Injection Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Nerve Block Injection by Type (2018-2034)
Figure 53. Global Revenue Market Share of Nerve Block Injection by Type (2018-2034)
Figure 54. Global Nerve Block Injection Price (US$/Unit) by Type (2018-2034)
Figure 55. Global Sales Market Share of Nerve Block Injection by Application (2018-2034)
Figure 56. Global Revenue Market Share of Nerve Block Injection by Application (2018-2034)
Figure 57. Global Nerve Block Injection Price (US$/Unit) by Application (2018-2034)
Figure 58. Nerve Block Injection Value Chain
Figure 59. Nerve Block Injection Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed